The Board of Queensland Bauxite (ASX:QBL) is pleased to announce that the Department of Natural Resources and Mines has now formally approved the work programme intended under the MDL.
Queensland Bauxite Ltd
Queensland Bauxite Limited (ASX:QBL) is an Australian listed company focused on the exploration and development of its bauxite tenements in Queensland and New South Wales. The Company's lead project is the South Johnstone Bauxite Deposit in northern Queensland which has rail running through the project area and is approximately 15-24 kilometres from the nearest deep water port. The Company intends to become a bauxite producer with a focus on commencing production at South Johnstone as early as possible. The Company also pursues additional investment opportunities, and has acquired a 55% shareholding in Medical Cannabis Limited, an Australian leader in the hemp and Cannabis industries.
The Board of Queensland Bauxite (ASX:QBL) is delighted to announce that Mineral Development License approval has been progressed for the South Johnstone Bauxite Project at Camp Creek in Queensland with the important decision received today from the DEHP to approve the amendment to our previous Environmental Authority, to allow for the work programme intended under the MDL.
Queensland Bauxite Ltd (ASX:QBL) is delighted to announce that its subsidiary company Medical Cannabis Limited has reported success with its previously announced winter trial crops.
During the June Quarter 2017, Queensland Bauxite Limited (ASX:QBL) continued to press to progress the development of its flagship South Johnstone DSO bauxite project in northern Queensland, with the Company aiming to generate positive net cash flows in the short term through the commencement of DSO bauxite production and shipping.
This is a reminder notice that your options to subscribe for ordinary fully paid shares in Queensland Bauxite Limited (ASX:QBL) will expire at 5:00pm Australian Western Standard Time on 31 July 2017.
Queensland Bauxite Ltd (ASX:QBL) is excited to announce that Medical Cannabis Limited has confirmed successful germination and growth rates of its pioneering winter Cannabis crop.
It has come the attention of Queensland Bauxite Ltd (ASX:QBL) that there has been some confusion between Andrew Kavasilas of Medical Cannabis Limited and Andrew Katelaris. Andrew Katelaris, Dr Pot, allegedly caught last week with cash and cannabis, and consequently arrested, is NOT the Andrew Kavasilas of Medical Cannabis Limited.
The directors of Queensland Bauxite Ltd (ASX:QBL) are excited to inform our shareholders that completion of the acquisition of 55% of MCL has occurred today with the issue of 49 million shares in QBL to the shareholders of MCL.
As the directors of Medical Cannabis Limited (MCL) are drafting a prospectus for an independent ASX listing of MCL, the Board of MCL in conjunction with the QBL (ASX:QBL) Board, have decided that the MCL Initial Public Offering (IPO) will be giving Queensland Bauxite shareholders preference to take up shares in the anticipated MCL Listing on ASX.
Queensland Bauxite Ltd (ASX:QBL) Andrew Kavasilas Interview Regarding Medical Cannabis Limited and Vitahemp
Andrew Kavasilas, Technical Director of Medical Cannabis Limited (MCL), has been interviewed by 2Ser 107.3 in relation to the work that he has been doing with Medical Cannabis Limited and Vitahemp, and in preparation for the upcoming Hemp Health and Innovation Expo, Australia's largest Cannabis Expo. Andrew also discussed general information on the industry and Cannabis.